A systematic review of placebo-controlled trials of topiramate: How useful is a multiple-indications review for evaluating the adverse events of an antiepileptic drug?

Donegan, Sarah; Dixon, Peter; Hemming, Karla; Tudur-Smith, Catrin; Marson, Anthony

Donegan, Sarah; Dixon, Peter; Hemming, Karla; Tudur-Smith, Catrin; Marson, Anthony.

Affiliation

Donegan S; Department of Biostatistics, University of Liverpool, Liverpool, United Kingdom.
Dixon P; Department of Molecular and Clinical Pharmacology, Clinical Sciences Centre, Liverpool, United Kingdom.
Hemming K; Health and Population Science, University of Birmingham, Birmingham, United Kingdom.
Tudur-Smith C; Department of Biostatistics, University of Liverpool, Liverpool, United Kingdom.
Marson A; Department of Molecular and Clinical Pharmacology, Clinical Sciences Centre, Liverpool, United Kingdom.

Epilepsia ; 56(12): 1910-20, 2015 Dec.

Article in En | MEDLINE | ID: mdl-26662191

Subject(s)

Anticonvulsants/adverse effects; Fructose/analogs & derivatives; Anticonvulsants/therapeutic use; Epilepsy/drug therapy; Fructose/adverse effects; Fructose/therapeutic use; Humans; Randomized Controlled Trials as Topic; Topiramate

Key words

Harms; Meta-analysis; Safety

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fructose / Anticonvulsants Type of study: Clinical_trials / Systematic_reviews Limits: Humans Language: En Journal: Epilepsia Year: 2015 Document type: Article Affiliation country: United kingdom Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google